current

Oslo, Norway
Investment Date: 2024

Specialty CDMO focused on aseptic and non-aseptic liquid manufacturing and blow-fill-seal (“BFS”) and nasal spray technologies

Private
Waltham, MA
Investment Date: 2023

Medical device manufacturer that specializes in designing, manufacturing, and selling organ transport and preservation devices

Private
Hyderabad India
Investment Date: 2022

Vertically integrated small molecule Contract Research, Development, and Manufacturing Organization (“CRDMO”)

Private
Texarkana, TX
Investment Date: 2022

Developer and manufacturer of innovative pharmaceuticals and over-the-counter (OTC) medicines

Private
Toronto, Canada
Investment Date: 2022

Specialty pharmaceutical company with a focus on injectable generic drugs sold through hospital channels

Private
LAVAL, CANADA
Investment Date: 2021

Fully-integrated CRO/CDMO platform, providing pharma and biotech a single outsourced partner from lead candidate selection to clinical proof-of-concept

Private
NORTH BRUNSWICK, N.J.
Investment Date: 2021

Specialty CDMO dedicated to developing and manufacturing enhanced formulations for pre-clinical, clinical stage drug candidates, and marketed drug products

Private
PLANTATION, FL
Investment Date: 2019

Contract development and manufacturing company of biologic drugs

Private
Ra’anana, Israel
Investment Date: 2018

Manufacturer of innovative gastro-intestinal endoscopy products

Private
FAIRFIELD, NJ
Investment Date: 2017

Generic pharmaceutical company that manufactures, markets, and distributes products to drug chains, wholesalers, and other channels

Private
HUNT VALLEY, MD
Investment Date: 2016

Contract development and manufacturing company

Private
Munich, Germany
Investment Date: 2015

Developer of proprietary formulation technology that addresses low bioavailability and solubility

Private
Gentofte, Denmark
Investment Date: 2015

Manufacturer of complex API's

Private
Princeton, NJ
Investment Date: 2014

Developer and marketer of complex generic pharmaceuticals.

Private

Realized

PEARL RIVER, NY
Investment Date: 2019

Fully integrated generic pharmaceutical company that develops complex API and injectable finished dosage products

Acquired by PAG
Mechanicsburg, PA
Investment Date: 2020

Specialty medical device company that commercializes products targeting gastroenterologists and interventional radiologists

Acquired by Laborie Medical Technologies
CEDAR KNOLLS, NJ
Investment Date: 2019

Global consumer healthcare platform focused on over-the-counter ("OTC") pharmaceuticals

Acquired by TA Associates
ROCKVILLE, MD
Investment Date: 2019

CDMO for viral vector products and services used in gene therapy

Acquired by Charles River Laboratories (NYSE: CRL)
Clearwater, FL
Investment Date: 2015

Contract developer and manufacturer of complex oral drugs

Acquired by NovaQuest Private Equity
Riviera Beach, FL
Investment Date: 2014

Integrated specialty pharmaceutical company leveraging proprietary formulation technology

Somerset, NJ
Investment Date: 2014

Developer and manufacturer of complex API's

Acquired by Medicure
Malvern, PA
Investment Date: 2014

Medtech company focused on surgical mesh products for soft tissue repair

Public (NASDAQ: TELA)
Cambridge, MA
Investment Date: 2014

Diagnostics and personalized medicine platform focused on Oncology

Private
Concord, Ontario, Canada
Investment Date: 2013

Developer of nasal and inhaled drug-device combination generic therapeutics

Sunnyvale, CA
Investment Date: 2013

Developer of injectable ophthalmic drug-device combination therapeutics

Acquired by EyePoint Pharmaceuticals (NASDAQ: EYPT)
Ahmedabad, India
Investment Date: 2012

Provider of specialty generic injectable drugs

Acquired by Baxter and shares delisted from the BSE
San Francisco, CA
Investment Date: 2011

Developer of instruments and microfluidic chips for cell based drug assays

Acquired by Cell Microsystems
Buena, NJ
Investment Date: 2009

Developer, manufacturer and marketer of topical and injectable pharmaceuticals

Public market exit
San Diego, CA
Investment Date: 2009

Protein expression company focused on development of biosimilar drugs

Public market exit
Amsterdam, Netherlands
Investment Date: 2006

Specialty pharmaceutical company focused on European markets

Private
Hayward, CA
Investment Date: 2005

Developer of automated bedside monitoring devices for critical care

Private
Mezzovico, Switzerland
Investment Date: 2004

Developer and manufacturer of orally dispersible tablet formulations

Private
Atlanta, GA
Investment Date: 2010

Specialty pharmaceutical company focused on cardiovascular and pediatric disorders

Acquired by KKR
Leiden, Netherlands
Investment Date: 2009

Specialty pharmaceutical company focused on controlled release formulations

Acquired by Dr. Reddy’s Laboratories
Cambridge, MA
Investment Date: 2007

Provider of dental implants

Acquired by AstraZeneca
Geneva, Switzerland
Investment Date: 2007

Developer, manufacturer and marketer of injectable biopolymers (fillers)

Acquired by Merz
Minneapolis, MN
Investment Date: 2007

Developer of novel electrosurgical tools for ENT and other surgical applications

Acquired by Medtronic
Berlin, Germany
Investment Date: 2005

Developer and manufacturer of peptide-based drugs for neglected diseases

IPO, Acquired by Shire Pharmaceuticals
Sunrise, FL
Investment Date: 2005

Developer and manufacturer of controlled release generic drugs

Acquired by Actavis
Chennai, India
Investment Date: 2005

Developer and manufacturer of APIs

Acquired by Private Equity Fund
San Francisco, CA
Investment Date: 2005

Marketer of in-licensed oncology products for Asian markets

Acquired by Management
Lenexa, KS
Investment Date: 2004

Provider of technology to enhance solubility and absorption of drugs

Acquired by Ligand
Tigard, OR
Investment Date: 2004

Developer of needle-free injection systems

Acquired by Inovio
Cranbury, NJ
Investment Date: 2003

Specialty pharmaceutical company focused on urology & endocrinology

IPO, Acquired by Indevus (Endo)
Anaheim, CA
Investment Date: 2003

Specialty pharmaceutical company focused on CNS indications

Public market exit
Carlsbad, CA
Investment Date: 2003

Contract manufacturer of viral vaccines and therapeutics

Acquired by Sigma-Aldrich
Amsterdam, Netherlands
Investment Date: 2003

Provider of R&D tools & services to pharmaceutical & chemical companies

Acquired by AESCAP
Grafton, WI
Investment Date: 2003

Developer and manufacturer of API's

Acquired by AMRI
Köln, Germany
Investment Date: 2002

Developer of proteins and enzymes for industrial & biopharmaceutical applications

Acquired by Bayer HealthCare
Investment Date: 2000
Pharma Marketing

A specialty pharmaceutical company with products marked in the U.S. and Europe. Acquired by Elan Corporation

Acquired by Elan Corporation
Pittsburgh, PA
Investment Date: 2001

Provider of hardware & software for radiation therapy

Acquired by North American Scientific
Cranbury, NJ
Investment Date: 2001

Developer, manufacturer and marketer of generic pharmaceuticals

Public market exit
Durham, NC
Investment Date: 2001

Developer of vaccines for treatment of cancer and infectious diseases

Public market exit
Philadelphia, PA
Investment Date: 1999

Provider of cardiac monitoring software

Public market exit
Bedminster, NJ
Investment Date: 2000

Commercial specialty pharmaceuticals company

Public market exit